REILLY ASSOCIATES
 WPAI References

Despiégel N, Danchenko N, François C, Lensberg B, Drummond MF. The use and performance of productivity scales to evaluate presenteeism in mood disorders. Value Health. 2012 Dec;15(8):1148-61.

Loeppke R, Hymel PA, Lofland JH, Pizzi LT, Konicki DL, Anstadt GW, Baase C, Fortuna J, Scharf T; American College of Occupational and Environmental Medicine.Health-related workplace productivity measurement: general and migraine-specific recommendations from the ACOEM Expert Panel.J Occup Environ Med. 2003;45(4):349-59.

Lynch W, Reidel JE, editors  Measuring employee productivity: a guide to self-assessment tools. Institute for Health and Productivity Management amd William M. Mercer, Inc., Virginia, 2001.

Prasad M, Shih YCT, Wahlqvist P, Shikiar R. A critical review of health-related productivity measures. Value in Health 2002;5(6):A535-6.

Prasad M, Shih YCT, Wahlqvist P, Shikiar R. A review of self-report instruments measuring health-related work productivity. Pharmacoeconomics 2004:22(4); 225-244.

Tang K, Boonen A, Verstappen SM, Escorpizo R, Luime JJ, Lacaille D, Fautrel B, Bosworth A, Cifaldi M, Gignac MA, Hofstetter C, Leong A, Montie P, Peterson IF, Purcaru O, Bombardier C, Tugwell PS, Beaton DE. Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research. J Rheumatol.2013 Oct 15.

Nocturia
Kobelt G, Borgstrom F, Mattiasson A.  Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia.  Br J Urol Int 2003;:9(3):190-5.

Sand PK, Dmochowski RR, Reddy J, van der Meulen EA. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep;190(3):958-64.

Weiss JP, Herschorn S, Albei CD, van der Meulen EA. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013 Sep;190(3):965-72.
Mental Health
Asami Y, Goren A, Okumura Y. Work productivity loss with depression, diagnosed and undiagnosed, among workers in an Internet-based survey conducted in Japan. J Occup Environ Med. 2015 Jan;57(1):105-10.

Beck A, Crain LA, Solberg LI, Unützer J, Maciosek MV, Whitebird RR, Rossom RC. The effect of depression treatment on work productivity. Am J Manag Care. 2014 Aug 1;20(8):e294-301

Beck A, Crain AL, Solberg LI, Unützer J, Glasgow RE, Maciosek MV, Whitebird R.  Severity of depression and magnitude of productivity loss. Ann Fam Med. 2011Jul-Aug;9(4):305-11.

Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL. Burden of Chronic Sleep
Maintenance Insomnia Characterized by Nighttime Awakenings Among Anxiety and
Depression Sufferers: Results of a National Survey. Prim Care Companion J Clin
Psychiatry. 2010;12(2). pii: PCC.09m00824.

Bolge SC, Samuel W.  Burden of illness of depression symptoms among patients with type 2 diabetes mellitus.  Poster presentation, ISPOR 14th Annual International Meeting, Orlando, FL, May 16, 2009.

Calleja JL, Bixquert M, Maldonado J; for the SINERGE Study Group. Impact of Nocturnal Heartburn on Quality of Life, Sleep, and Productivity: The SINERGE Study. Dig Dis Sci. 2006 Jul 29; [Epub ahead of print] 

Chirban JT, Jacobs RJ, Warren J, Prakash E, Sodomsky ME, Clarke JF, et al.  The 36-Item Short Form Health Survey (SF-36) and the Work Productivity and Activity Impairment (WPAI) Questionnaire in panic disorder.  Dis Manage Health Outcomes 1997; 1(3):154-164.

​Despiégel N, Danchenko N, François C, Lensberg B, Drummond MF. The use and
performance of productivity scales to evaluate presenteeism in mood disorders.
Value Health. 2012 Dec;15(8):1148-61.

Erickson SR, Guthrie S, Vanetten-Lee M, Himle J, Hoffman J, Santos SF, Janeck  AS, Zivin K, Abelson JL. Severity of anxiety and work-related outcomes of patients with anxiety disorders. Depress Anxiety. 2009 Oct 19. [Epub ahead of print] 

Erickson S, Guthrie S, Abelson J.  Health status and work-related outcomes of patients with anxiety disorders and depression.  Poster presentation, ISPOR 13th Annual International Meeting Toronto, Ontario, Canada, May 03, 2008.

Ettigi P, Meyerhoff AS, Chirban JT, Jacobs RJ, Wilson RR.  The quality of life and employment in panic disorder. J Nerv Ment Dis, 1997; 185(6):368-72.

Jacobs RJ, Davidson JR, Gupta S, Meyerhoff AS.  The effects of clonazepam on quality of life and work productivity in panic disorder.  Am J Man Care 1997; 3:1187-1196.

Jain G, Roy A, Harikrishnan V, Yu S, Dabbous O, Lawrence C. Patient-reported Depression Severity Measured by the PHQ-9 and Impact on Work Productivity: Results From a Survey of Full-time Employees in the United States. J Occup Environ Med. 2013 Feb 22. [Epub ahead of print]

Lam RW, Endicott J, Hsu MA, Fayyad R, Guico-Pabia C, Boucher M. Predictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxine. Int Clin Psychopharmacol. 2014 Feb 27.

Trivedi MH, Morris DW, Wisniewski SR, Lesser I, Nierenberg AA, Daly E, Kurian BT, Gaynes BN, Balasubramani GK, Rush AJ. Increase in Work Productivity of Depressed Individuals With Improvement in Depressive Symptom Severity. Am J Psychiatry. 2013 Apr 5. [Epub ahead of
print]

Trotter VK, Lambert MJ, Burlingame GM, Rees F, Carpenter BN, Steffen PR, Jackson A, Eggett D. Measuring work productivity with a mental health self-report measure. J Occup Environ Med. 2009;51(6):739-46.

Wiegand B, Luedtke K, Friscia D, Nair M, Aleles M, McCloskey R. Efficacy of a 
comprehensive program for reducing stress in women: A prospective, randomized
trial. Curr Med Res Opin. 2010;26(4):991-1002.

Wittchen HU, Beloch E.  The impact of social phobia on quality of life.  International Clinical Psycopharmacology 1996; II(S3):15-23.

Zhang W, Ross J, Davidson JR. Posttraumatic stress disorder in callers to the Anxiety Disorders Association of America. Depress Anxiety. 2004;19(2):96-104.

Reviews  
Restless Legs Syndrome
Allen RP, Bharmal M, Calloway M. Prevalence and disease burden of primary restless legs syndrome: Results of a general population survey in the United States. Mov Disord. 2010 Nov 10. [Epub ahead of print] 

McLeod LD, Fehnel SE, Zografos LJ et al.  The impact of restless Legs syndrome on various dimensions of life: results of a web-based patient survey.  International Society of Pharmacoeconomics and Outcomes Research, 12th Annual International Meeting, May 21-23, 2007.  Arlington, VA.

Trenkwalder C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd AW,
Tidswell P, Saletu-Zyhlarz G, Telstad W, Ferini-Strambi L.  Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.  J Neurol Neurosurg Psychiatry. 2004;75(1):92-7.

Ariza-Ariza R, Hernández-Cruz B, Navarro-Compán V, Leyva Pardo C, Juanola X, Navarro-Sarabia F. A comparison of telephone and paper self-completed questionnaires of main patient-related outcome measures in patients with ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 2013 Jun 21.

*Brozek JL, Guyatt GH, Heels-Ansdell D, Degl'Innocenti A, Armstrong D, Fallone CA, Wiklund I, van Zanten SV, Chiba N, Barkun AN, Akl EA, Schünemann HJ. Specific HRQL instruments and symptom scores were more responsive than preference-based generic instruments in patients with GERD. J Clin Epidemiol. 2009;62(1):102-10. Epub 2008 Jul 10.

Bushnell DM, Galani C, Martin ML, Ricci JF, Reilly MC, Patrick DL.Validation of EDC versions of IBS-QOL, EQ-5D and WPAI-IBS questionnaires.Value in Health 2005 (8):383.  (Presented ISPOR 10th Annual International Meeting, Washington DC, May 15-18, 2005.)

Bushnell DM, Reilly MC, Galani C, Martin ML, Ricci JF, , Patrick DL, McBurney C. Validation of EDC versions of IBS-QOL, EQ-5D and WPAI-IBS questionnaires.   Value in Health. 2006; 9(2):98-105.

Chen H, Blanc PD, Chawla A, Hayden M, Bleeker ER, Lee JH.  Assessing productivity impairment in patients with severe or difficult to treat asthma: validation of the Work Productivity and Activity Impairment- Asthma questionnaire.  J Allergy Clin Immunol 2006; 117(2):S181.

Chen H, Blanc PD, Hayden ML, Bleecker ER, Chawla A, Lee JH, TENOR Study Group.  Assessing productivity loss and activity impairment in severe or difficult-to-treat asthma. Value in Health (OnlineEarly Articles). doi:10.1111/j.1524-4733.2007.00229.x.

Ciconelli RM, Soarez PC, Kowalski CC, Ferraz MB.  The Brazilian Portuguese version of the Work Productivity and Activity Impairment: General Health (WPAI-GH) Questionnaire. Sao Paulo Med J. 2006;124(6):325-332. 

Crawford B, Okuda M, Leahy MJ.  The RQLQ AND WPAI-AS questionnaires are valid, reliable measures of QOL in Japanese pateints with seasonal allergic rhinits. Presented ISPOR First Asia-Pacific Conference, 1-3 September 2003, Kobe, Japan.

Erickson SR, Guthrie S, Vanetten-Lee M, Himle J, Hoffman J, Santos SF, Janeck  AS, Zivin K, Abelson JL. Severity of anxiety and work-related outcomes of patients with anxiety disorders. Depress Anxiety. 2009 Oct 19. [Epub ahead of print] 

Gawlicki MC, Reilly MC, Popielnicki A, Reilly K.  Linguistic validation of the US Spanish Work Productivity and Activity Impairment questionnaire, general health version (WPAI:GH). Value in Health 2006; 9(3):199-204.

Gawlicki MC, Reilly MC, Popielnicki A, Reilly K.  Linguistic validation of the US Spanish Work Productivity and Activity Impairment questionnaire, general health version (WPAI:GH). Poster presentation ISPOR Tenth Annual International Meeting, May 17, 2005, Washington, DC.

Giovannetti ER, Wolff JL, Frick KD, Boult C. Construct Validity of the Work Productivity and Activity Impairment Questionnaire across Informal Caregivers of Chronically Ill Older Patients. Value Health. 2009 Apr 23. [Epub ahead of print]

Lambert J, Hansen BB, Arnould B, Grataloup G, Guillemin I, Højbjerre L, Strandberg-Larsen M, Reilly MC. Linguistic Validation into 20 Languages and Content Validity of the Rheumatoid Arthritis-Specific Work Productivity and Activity Impairment Questionnaire. Patient. 2014 Mar 27. 

Litaker D.  New technology in quality of life research: are all computer-assisted approaches equal? Qual Life Res 2003;12(4):387-93

Reilly MC, Bracco A, Ricci J-F, Santoro J, Stevens T.  The validity and accuracy of the Work Productivity and Activity Impairment questionnaire - irritable bowel syndrome version (WPAI:IBS).   Aliment  Pharmacol Ther 2004; 20:459-467.

*Reilly MC, Brown MCJ, Brabant Y, et al. Minimally important difference for WPAI:CD scores: Defining relevant impact on work productivity in active Crohn’s disease (Abst 962). Presented at the American College of Gastroenterology Annual Scientific Meeting; Philadelphia. October 12 to 17, 2007.

*Reilly MC, Gerlier L, Brabant Y, Brown, M. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment questionnaire in Crohn’s disease. Clin Ther. 2008; 30(2):393-404.

Reilly MC, Gerlier L, Brown, M. Discriminant validity of the Work Productivity and Activity Impairment questionnaire in patient’s with Crohn’s disease. Value in Health. 2006; 9(6):A246. (Abstract.)

Reilly MC, Gerlier L, Brown, M. Discriminant validity of the Work Productivity and Activity Impairment questionnaire in patient’s with Crohn’s disease. Presented ISPOR 9th Annual European Congress, Copenhagen, Denmark, October 28-30, 2006.

*Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D,  Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis . Rhuematology 2010; Jan 25. [Epub ahead of print].

*Reilly M, Lavin P, Kahler K.  Validation of quality of life and work productivity instruments in patients with chronic hand dermatitis.  Presented American Academy of Dermatology, 60th Annual Meeting, Feb. 22-27, 2002.

*Reilly MC, Lavin PT, Kahler KH, Pariser DM.  Validation of the Dermatology Life Quality Index (DLQI) and the Work Productivity and Activity Impairment: Chronic Hand Dermatitis Questionnaire (WPAI-ChHD) in Chronic Hand Dermatitis (ChHD).  J Am Academy Dermatol.2003;48:128-30.

Reilly MC, McBurney CR,. Bracco A.  Work absenteeism in irritable bowel syndrome (IBS): measuring days versus hours missed.  Poster presentation, ISPOR 8th Annual European Congress, Nov 6-8, 2005, Florence, Italy. 

*Reilly MC, McBurney CR.  Responsiveness of the Work Productivity and Activity Impairment Questionnaire for Irritable Bowel Syndrome with Constipation (WPAI:IBS-C) to clinically meaningful change.  Poster presentation, American College of Gastroenterology October 30, 2005, Honolulu, Hawaii.

Reilly M, Mitchell I, Gooch K, Vo P, Virabhak S, Lorimer M, Ruff M,Seidenberg J,Khong H Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI:CHRI) in Germany and Canada. Poster presentation at ISPOR Asia, Taipei, Taiwan, Sept 4 2012.

Reilly MC, Relkin N, Zbrozek A. Development and testing of a new outcome measure of relationship between patients with Alheimer's disease and their partners.  Am J Alzheimer's Dis and Other Dementias. 2006; 21(4):249-257.

Reilly MC, Tanner A, Meltzer EO.  Allergy impairment questionnaires: validation studies.  J Allergy Clin Immunology 1996;97:1:3:430 (abstract).

Reilly MC, Tanner A, Meltzer EO. Work, classroom and activity impairment instruments: validation studies in allergic rhinitis.  Clinical Drug Investigations 1996; 11(5):278-288.  Please note there is an error in the sample size calculations. We state (page 287) that 201 patients per treatment group would be required to detect a 5% difference in overall work impairment and 1,256 patients would be required to detect a 2% difference.  The numbers should be 190 patients and 1,180 patients, respectively.  For overall classroom impairment, the sample size per treatment group should be 290 patients, not 192 patients.

Reilly MC, Zbrozek AS, Dukes EM.  The validity and reproducibility of a work productivity and activity impairment instrument.  PharmacoEconomics 1993; 4(5):353-65.

*Thomsen OØ, Brown M, Purcaru, Schreiber.  Relationship between work productivity, daily activities and clinical endpoints in Crohn’s disease: data from Precise 2. Amer J Gastroent. 2006:101(s2). (Abstract)

*Thomsen OØ, Brown M, Purcaru, Schreiber.  Relationship between work productivity, daily activities and clinical endpoints in Crohn’s disease: data from Precise 2. Presentation at American College of Gastroenterology (ACG), 71st Annual Scientific Meeting, October 20-25 2006, Las Vegas, NV.

Wahlqvist P, Carlsson J, Stalhammar NO, Wiklund I.  Validity of a Work Productivity and Activity Impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD)- results from a cross-sectional study.  Value in Health 2002; 5:106-113.

Wahlqvist P, Carlsson J. Correlation between different productivity variables obtained from the WPAI-GERD questionnaire. Value in Health 2002;5(6):A505-6.

*Wahlqvist P, Guyatt GH, Armstrong D, Degl'innocenti A, Heels-Ansdell D, El-Dika
S, Wiklund I, Fallone CA, Tanser L, Veldhuyzen van Zanten S, Austin P, Barkun AN, Chiba N, Schünemann HJ.The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD): Responsiveness to Change and English Language Validation. Pharmacoeconomics. 2007;25(5):385-96.

*Wahlqvist P, Guyatt G, Armstrong D, Austin P, Barkun A, Chiba N, degl'Innocenti A, El-Dika S, Fallone C, Heels-Ansdell D, Tanser L, Veldhuyzen van Zanten S, Wiklund I, Schünemann H. Responsiveness to change and English language validation of the WPAI-GERD questionnaire - results from a Canadian study. Value in Health 2004;7(3):A349.

*Wahlqvist P, Guyatt G, Armstrong D, Austin P, Barkun A, Chiba N, degl'Innocenti A, El-Dika S, Fallone C, Heels-Ansdell D, Tanser L, Veldhuyzen van Zanten S, Wiklund I, Schünemann H. Responsiveness to change and English language validation of the WPAI-GERD questionnaire - results from a Canadian study. Presented ISPOR Congress, May 2004.

*Wahlqvist P, Medin J, Karlsson M, Reilly MC. Responsiveness to change and construct validity of the Work Productivity and Activity Impairment questionnaire for gastroesophageal reflux disease (WPAI:GERD) in Swedish patients.  Poster presentation, ISPOR 14th Annual International Meeting, Orlando, FL, May 16, 2009.

Vergara M, Montserrat A, Casellas F, Maudsley M, Gallardo O, Ricart E, Calvet X. Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version. Eur J Gastroenterol Hepatol. 2009 Apr 28.[Epub ahead of print] PubMed PMID: 19404204.

Vergara M, Montserrat A, Casellas F, Villoria A, Suarez D, Maudsley M,Gallardo O, Ricart E, Calvet X. A New Validation of the Spanish Work Productivity and Activity Impairment Questionnaire-Crohn's Disease Version. Value Health. 2011 Sep-Oct;14(6):859-61. Epub 2011 May 28.

Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH. Validity of the Work Productivity and Activity Impairment questionnaire - General Health version (WPAI-GH) in patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12(5):R177. [Epub ahead of print]

Validation Studies  (* responsivenss tested)
Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101(11): 1388-95.

Coyne KS, Sexton CC, Thompson CL, Clemens JQ, Chen CI, Bavendam T, Dmochowski R. Impact of overactive bladder on work productivity. Urology. 2012 Jul;80(1):97-103.

Lee HE, Cho SY, Lee S, Kim M, Oh SJ. Short-term Effects of a Systematized Bladder Training Program for Idiopathic Overactive Bladder: A Prospective Study. Int Neurourol J. 2013 Mar;17(1):11-7. doi: 10.5213/inj.2013.17.1.11. Epub 2013 Mar 31.

Mitcheson HD, Roy JB, Gilmet G, Marshall TS, Shannon JB.  Impact of solifenacin on symptom bother, health-related quality of life, work productivity, treatment satisfaction, and symptoms in patients with overactive bladder: results from VIBRANT. Poster presentation, ISPOR 14th Annual International Meeting, Orlando, FL, May 16, 2009.

Péntek M, Gulácsi L, Majoros A, Piróth C, Rubliczky L, Böszörményi Nagy G,Törzsök F, Timár P, Baji P, Brodszky V. [Health related quality of life andproductivity of women with overactive bladder]. Orv Hetil. 2012 Jul 8;153(27):1068-76. Hungarian. 

Tang DH, Colayco DC, Khalaf KM, Piercy J, Patel V, Globe D, Ginsberg D. Impact of urinary incontinence on healthcare resource utilization, health-related quality of life and productivity in patients with overactive bladder. BJU Int. 2014 Mar;113(3):484-91.

Tang DH, Colayco D, Piercy J, Patel V, Globe D, Chancellor MB. Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity. BMC Neurol. 2014 Apr 4;14(1):74.

Zinner N, Noe L, Rasouliyan L, Marshall T, Seifeldin R.  Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER. Curr Med Res Opin. 2008 Apr 17; [Epub ahead of print]

Zinner N, Noe L, Rasouliyan L, Marshall T, Runken MC, Seifeldin R. Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis. Am J Geriatr Pharmacother. 2009 Dec;7(6):373-82.



Overactive Bladder
Obesity/ Nutrition
Agarwal U, Mishra S, Xu J, Levin S, Gonzales J, Barnard ND. A Multicenter Randomized Controlled Trial of a Nutrition Intervention Program in a Multiethnic Adult Population in the Corporate Setting Reduces Depression and Anxiety and Improves Quality of Life: The GEICO Study. Am J Health Promot. 2014 Feb 13.

Bedrosian RC, Striegel RH, Wang C, Schwartz S. Association of binge eating with work productivity impairment, adjusted for other health risk factors. J Occup Environ Med. 2012 Apr;54(4):385-93.

Kannan H, Thompson S, Bolge SC. Economic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertension among individuals who are overweight or obese. J Occup Environ Med. 2008;50(5):542-9.

Krishnarajah G, DiBonaventura M, Wagner S, Gupta S.  The effect of weight changes on health-related quality of life and work impairment in patients with type 2 diabetes. Poster presentation, ISPOR 14th Annual International Meeting, Orlando, FL, May 16, 2009.

Rodbard HW, Fox KM, Grandy S; Shield Study Group. Impact of obesity on work
productivity and role disability in individuals with and at risk for diabetes mellitus. Am J Health Promot. 2009;23(5):353-60. 

Stewart WF, Chapman RH, Gavin JR, Fox KM, Grandy, S.  Impact of obesity on work productivity among individuals with Type 2 diabetes mellitus and varied levels of cardiometabilic risk.  American Diabetes Association, 2007, abstract 0952-P

Striegel RH, Bedrosian R, Wang C. Comparing work productivity in obesity and binge eating. Int J Eat Disord. 2012 Oct 9. doi: 10.1002/eat.22069. [Epub ahead of print]

Pain
Bell T, Annunziata K, Leslie JB. Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag. 2009;5(3):137-44.

Cepeda MS, Sutton A, Weinstein R, Kim M. Effect of Tapentadol Extended Release on Productivity: Results From an Analysis Combining Evidence From Multiple Sources. Clin J Pain. 2011 Jun 3. [Epub ahead of print]

Coyne KS, LoCasale RJ, Datto CJ, Sexton CC, Yeomans K, Tack J. Opioid-induced constipation in patients with chronic noncancer pain in the USA, Canada, Germany, and the UK: descriptive analysis of baseline patient-reported outcomes and retrospective chart review. Clinicoecon Outcomes Res. 2014 May 23;6:269-81.

Goren A, Mould-Quevedo J, daCosta DiBonaventura M. Prevalence of Pain Reporting and Associated Health Outcomes Across Emerging Markets and Developed Countries. Pain Med. 2014 Sep 12.

Kronborg C, Handberg G, Axelsen F.  Health care costs, work productivity and activity impairment in non-malignant chronic pain patients. Eur J Health Econ. 2009;10(1):5-13. Epub 2008 Feb 7.

Langley PC, Van Litsenburg C, Cappelleri JC, Carroll D. The burden associated with neuropathic pain in Western Europe. J Med Econ. 2012 Sep 12. 

Skljarevski V, Zhang S, Desaiah D, Alaka KJ, Palacios S, Miazgowski T, Patrick
K. Duloxetine Versus Placebo in Patients With Chronic Low Back Pain: A 12-Week,
Fixed-Dose, Randomized, Double-Blind Trial. J Pain. 2010 May 14.
Sleep
Women's Health 
Dibonaventura MD, Chandran A, Hsu MA, Bushmakin A. Burden of vasomotor symptoms in France, Germany, Italy, Spain, and the United Kingdom. Int J Womens Health. 2013 May 24;5:261-9.

Fourquet J, Báez L, Figueroa M, Iriarte RI, Flores I. Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril. 2011 May 28. [Epub ahead of print]

Heinemann LA, Minh TD, Filonenko A, Uhl-Hochgräber K. Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism andproductivity. Womens Health Issues. 2010;20(1):58-65.

Jayathunge MP, Bowanwatanuwong C, Maek-A-nantawat W, Pitisuttithum BP.
Psychosocial burden of abnormal pap smears among HIV-infected women at Chon Buri 
hospital, Thailand. Southeast Asian J Trop Med Public Health. 2010;41(1):224-34.

Phonrat B, Ruengkris T, Naksrisook S, Intalapaporn K, Jirakorbchaipong P, Pitisuttithum P.  Psychosocial burden of women with abnormal Pap smears.  Southeast Asian J Trop Med Public Health. 2009;40(3):593-601.

Schiola A, Lowin J, Lindemann M, Patel R, Endicott J. The burden of moderate/severe premenstrual syndrome and premenstrual dysphoric disorder in a cohort of latin american women. Value Health. 2011 Jul-Aug;14(5 Suppl 1):S93-5.

Wiegand B, Luedtke K, Friscia D, Nair M, Aleles M, McCloskey R. Efficacy of a 
comprehensive program for reducing stress in women: A prospective, randomized
trial. Curr Med Res Opin. 2010;26(4):991-1002.

Yang M, Hammond GC, Yarlas AS, Gricar JA.  Assessing work productivity impairment in premenstrual syndrome and premenstrual dysphroric disorder.  Poster presentation, ISPOR 14th Annual International Meeting, Orlando, FL, May 16, 2009.
Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL. Burden of Chronic Sleep
Maintenance Insomnia Characterized by Nighttime Awakenings Among Anxiety and
Depression Sufferers: Results of a National Survey. Prim Care Companion J Clin
Psychiatry. 2010;12(2). pii: PCC.09m00824.

Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings. Popul Health Manag. 2010;13(1):15-20. 

Bolge SC, Balkrishnan R, Kannan H, Seal B, Drake CL. Burden associated with
chronic sleep maintenance insomnia characterized by nighttime awakenings among
women with menopausal symptoms. Menopause. 2009 Aug 27. [Epub ahead of print]

Bolge SC, Doan JF, Kannan H, Baran RW.  Association of insomnia with quality of life, work productivity, and activity impairment. Qual Life Res 2009;18(4):415-22.2009 Mar 14. [Epub ahead of print]

Dean B, Aguilar D, Shapiro C, Orr WC, Isserman JA, Calimlim B, Rippon GA.
Impaired health status, daily functioning, and work productivity in adults with excessive sleepiness. J Occup Environ Med. 2010;52(2):144-9.

Moline M, DiBonaventura Md, Shah D, Ben-Joseph R. Impact of middle-of-the-night awakenings on health status, activity impairment, and costs. Nat Sci Sleep. 2014 Jul 23;6:101-11. 

Multiple Sclerosis
Coyle PK, Cohen BA, Leist T, Markowitz C, Oleen-Burkey M, Schwartz M, Tullman MJ, Zwibel H. Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes. BMC Neurol. 2014 Mar 13;14(1):49. 

Glanz BI, Dégano IR, Rintell DJ, Chitnis T, Weiner HL, Healy BC. Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life. Value Health. 2012 Dec;15(8):1029-35.

Gupta S, Goren A, Phillips AL, Dangond F, Stewart M. Self-reported severity among patients with multiple sclerosis in the U.S. and its association with health outcomes. Mult Scler Relat Disord. 2014 Jan;3(1):78-88.

Shields S, Parkes L. Baseline responses of multiple sclerosis patients  participating in the proms survey: impact of disease-modifying therapies and support services on patient-reported outcomes. J Neurol Neurosurg Psychiatry.  2013 Nov;84(11):e2.

Stockl KM, Shin JS, Gong S, Harada AS, Solow BK, Lew HC. Improving patient self-management of multiple sclerosis through a disease therapy management program. Am J Manag Care. 2010 Feb;16(2):139-44
Ulcerative Colitis
Gibson PR, Vaizey C, Black CM, Nicholls R, Weston AR, Bampton P, Sparrow M, Lawrance IC, Selby WS, Andrews JM, Walsh AJ, Hetzel DJ, Macrae FA, Moore GT, Weltman MD, Leong RW, Fan T. Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: A cross-sectional, observational study. J Crohns Colitis. 2013 Dec 14.

Kane S, Yen L, Yarlas A, Karlstadt R, Solomon D, Abhyankar B, Hodgkins P. Work productivity and activity limitation in patients with ulcerative colitis: the impact of treatment with MMX® mesalamine. Third biennial conference of the American Society of Health Economics, June 21, 2010.

Meijs S, Gardenbroek TJ, Sprangers MA, Bemelman WA, Buskens CJ, D'Haens GR, Löwenberg M. Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents. J Crohns Colitis. 2014 Jan 10.

Mukhekat V, Ahmad I, Merali Y, Aldulaimi D. PTU-078 The Application Of A Markov Model For Evauating Asa Therapy For Ulcerative Colitis. Gut. 2014 Jun;63 Suppl 1:A73.

Yarlas A, Yen L, Hodgkins P. The relationship among multiple patient-reported outcomes measures for patients with ulcerative colitis receiving treatment with MMX(®) formulated delayed-release mesalamine. Qual Life Res. 2014 Sep 6.


Rhinosinusitis 
Bikhazi N, Light J, Schwartz M, Truitt T, Cutler J, Investigators RS. Standalone balloon dilation versus sinus surgery for chronic rhinosinusitis: A prospective, multicenter, randomized, controlled trial with 1-year follow-up. Am J Rhinol Allergy. 2014 May 12.

Stankiewicz J, Tami T, Truitt T, Atkins J, Winegar B, Cink P, Schaeffer BT, Raviv J, Henderson D, Duncavage J, Hagaman D. Impact of chronic rhinosinusitis on work productivity through one-year follow-up after balloon dilation of the ethmoid infundibulum. Int Forum Allergy Rhinol. 2011 Jan;1(1):38-45. doi:10.1002/alr.20008. Epub 2011 Feb 8.

Respiratory
Reilly M, Mitchell I, Gooch K, Vo P, Virabhak S, Lorimer M, Ruff M,Seidenberg J,Khong H Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI:CHRI) in Germany and Canada. Poster presentation at ISPOR Asia, Taipei, Taiwan, Sept 4 2012. 
Neurology
Colamonico J, Formella A, Bradley W. Pseudobulbar affect: burden of illness in the USA. Adv Ther. 2012 Sep;29(9): 775-98. doi: 10.1007/s12325-012-0043-7. Epub 2012 Aug 30.
Voice Disorders
Isetti D, Meyer T. Workplace Productivity and Voice Disorders: A Cognitive Interviewing Study on Presenteeism in Individuals With Spasmodic Dysphonia. J Voice. 2014 Jun 24. pii: S0892-1997(14)00067-8. 

Meyer TK, Hu A, Hillel AD. Voice disorders in the workplace: Productivity in spasmodic dysphonia and the impact of botulinum toxin. Laryngoscope. 2013 Nov:123 Suppl 6:S1-14.


PAD
Marrett E, Dibonaventura MD, Zhang Q. Burden of peripheral arterial disease in Europe and the United States: a patient survey. Health Qual Life Outcomes. 2013 Oct 22;11(1):175.
Urinary Incontinence
Goren A, Zou KH, Gupta S, Chen C. Direct and indirect cost of urge urinary incontinence with and without pharmacotherapy. Int J Clin Pract. 2013 Dec 22. 
Substance Abuse
Vietri J, Joshi AV, Barsdorf AI, Mardekian J. Prescription Opioid Abuse and Tampering in the United States: Results of a Self-Report Survey. Pain Med. 2014 Jun 14. 


Spondylarthritis
Haglund E, Petersson IF, Bremander A, Bergman S. Predictors of Presenteeism and Activity Impairment Outside Work in Patients with Spondyloarthritis. J Occup Rehabil. 2014 Aug 31.